Series A financing round lays foundation for international growth of digital cancer therapeutics Mika
New investors with a successful track record in digital oncology support German Digital Therapeutics (DTx) company Fosanis to broaden patient access of Mika – an app-based DTx platform empowering people affected by cancer. Berlin-based digital health company Fosanis, the developer of Mika, Germany’s first prescription DTx for all oncological indications, closed a series A funding […]
